Using Metabolomics as a Tool for Monitoring Drug Efficacy, Disease Progression and Patient Stratification in DiabetesThursday, 10 May 2012 at 09:00 Add to Calendar ▼2012-05-10 09:00:002012-05-10 10:00:00Europe/LondonUsing Metabolomics as a Tool for Monitoring Drug Efficacy, Disease Progression and Patient Stratification in Diabetes SELECTBIOenquiries@selectbiosciences.com Metabolomics has been demonstrated to be high throughput and relatively cheap for biomarker discovery. I will outline how we are using this approach in human studies and animal models to identify metabolic biomarkers to monitor drug efficacy, monitor disease progression and undertake patient stratification as a tool for personalised medicine. |